Target EphA2 receptor for cancer therapy

被引:0
|
作者
Wang, Si [1 ]
Stebbins, John [1 ]
Noberini, Roberta [1 ]
Zhang, Ziming [1 ]
Pellecchia, Maurizio [1 ]
Pasquale, Elena [1 ]
Kitada, Shinichi [1 ]
Fisher, Paul [1 ]
机构
[1] Sanford Burnham Med Res Inst, Ctr Canc, La Jolla, CA 92130 USA
关键词
D O I
暂无
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
342-MEDI
引用
收藏
页数:1
相关论文
共 50 条
  • [31] EGFR and EGFRvIII induces expression of the proangiogenic receptor EphA2 in cancer cells
    Bjerregaard, Alice
    Pedersen, Mikkel W.
    Pedersen, Nina
    Poulsen, Hans S.
    CANCER RESEARCH, 2006, 66 (08)
  • [32] Inhibition of EphA2 receptor tyrosine kinase activity by dasatinib in pancreatic cancer
    Chang, Qing
    Jorgensen, Claus
    Pawson, Tony
    Hedley, David W.
    MOLECULAR CANCER THERAPEUTICS, 2007, 6 (12) : 3584S - 3584S
  • [33] EphA2 organization and dynamics in cancer cells
    Bowman, Deanna Meredith
    Shi, Xiaojun
    Hapiak, Vera
    Zheng, Ji
    Muller-Greyen, Jeannine
    Lingerak, Ryan
    Buck, Matthias
    Wang, Bing-Cheng
    Smith, Adam
    FASEB JOURNAL, 2017, 31
  • [34] Examining EphA2 expression in Colorectal Cancer
    Lyons, Nicholas
    Hooper, John
    Kryza, Thomas
    Clark, David
    Riddell, Andrew
    BJS-BRITISH JOURNAL OF SURGERY, 2022, 109
  • [35] EpHA2 is an essential driver of invasion and a novel target in KRAS mutant colorectal cancer
    Dunne, Philip D.
    McArt, Darragh G.
    Blayney, Jaine K.
    Dasgupta, Sonali
    Salto-Tellez, Manuel
    Johnston, Patrick G.
    Van Schaeybroeck, Sandra
    CANCER RESEARCH, 2014, 74 (19)
  • [36] Functional Oligomerization of the EphA2 Receptor Tyrosine Kinase
    Shi, Xiaojun
    Lingrak, Ryan
    Cuizon, Carmelle
    Toth, Paul
    Zheng, Ji
    Smith, Adam
    Wang, Bingcheng
    BIOPHYSICAL JOURNAL, 2020, 118 (03) : 97A - 97A
  • [37] A role of the SAM domain in EphA2 receptor activation
    Xiaojun Shi
    Vera Hapiak
    Ji Zheng
    Jeannine Muller-Greven
    Deanna Bowman
    Ryan Lingerak
    Matthias Buck
    Bing-Cheng Wang
    Adam W. Smith
    Scientific Reports, 7
  • [38] Inhibition of retinal neovascularization by soluble EphA2 receptor
    Chen, J
    Hicks, D
    Brantley-Sieders, D
    Cheng, N
    McCollum, GW
    Qi-Werdich, X
    Penn, J
    EXPERIMENTAL EYE RESEARCH, 2006, 82 (04) : 664 - 673
  • [39] A role of the SAM domain in EphA2 receptor activation
    Shi, Xiaojun
    Hapiak, Vera
    Zheng, Ji
    Muller-Greven, Jeannine
    Bowman, Deanna
    Lingerak, Ryan
    Buck, Matthias
    Wang, Bing-Cheng
    Smith, Adam W.
    SCIENTIFIC REPORTS, 2017, 7
  • [40] Antiangiogenic and antitumor efficacy of EphA2 receptor antagonist
    Dobrzanski, P
    Hunter, K
    Jones-Bolin, S
    Chang, H
    Robinson, C
    Pritchard, S
    Zhao, H
    Ruggeri, B
    CANCER RESEARCH, 2004, 64 (03) : 910 - 919